5 Health Services Stocks Pushing The Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 125 points (-0.8%) at 16,333 as of Tuesday, Jan. 21, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,733 issues advancing vs. 1,234 declining with 157 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.1%. Top gainers within the industry include Edwards Life ( EW), up 1.7%, and Fresenius Medical Care AG & Co. KGaA ( FMS), up 1.0%. On the negative front, top decliners within the industry include Community Health Systems ( CYH), down 3.9%, Mindray Medical International Limited ADR r ( MR), down 3.4%, Universal Health Services ( UHS), down 2.7% and Baxter International ( BAX), down 0.5%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. DaVita HealthCare Partners ( DVA) is one of the companies pushing the Health Services industry higher today. As of noon trading, DaVita HealthCare Partners is up $0.50 (0.8%) to $65.33 on light volume. Thus far, 773,525 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 2.1 million shares. The stock has ranged in price between $64.78-$65.55 after having opened the day at $65.39 as compared to the previous trading day's close of $64.83.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $13.8 billion and is part of the health care sector. The company has a P/E ratio of 24.4, above the S&P 500 P/E ratio of 17.7. Shares are up 2.3% year-to-date as of the close of trading on Friday. Currently there are 9 analysts who rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full DaVita HealthCare Partners Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, Boston Scientific ( BSX) is up $0.34 (2.5%) to $13.85 on average volume. Thus far, 8.1 million shares of Boston Scientific exchanged hands as compared to its average daily volume of 11.8 million shares. The stock has ranged in price between $13.62-$13.92 after having opened the day at $13.72 as compared to the previous trading day's close of $13.51.

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. Boston Scientific has a market cap of $18.0 billion and is part of the health care sector. Shares are up 12.4% year-to-date as of the close of trading on Friday. Currently there are 5 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 14 rate it a hold.

TheStreet Ratings rates Boston Scientific as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and compelling growth in net income. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Boston Scientific Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, WellPoint ( WLP) is up $1.22 (1.4%) to $86.71 on light volume. Thus far, 774,213 shares of WellPoint exchanged hands as compared to its average daily volume of 2.3 million shares. The stock has ranged in price between $85.54-$87.17 after having opened the day at $85.78 as compared to the previous trading day's close of $85.49.

WellPoint, Inc., a health benefits company, through its subsidiaries, offers network-based managed care plans to large and small employer, individual, Medicaid, and senior markets in the United States. The company operates through three segments: Commercial, Consumer, and Other. WellPoint has a market cap of $25.3 billion and is part of the health care sector. The company has a P/E ratio of 9.2, below the S&P 500 P/E ratio of 17.7. Shares are down 7.5% year-to-date as of the close of trading on Friday. Currently there are 5 analysts who rate WellPoint a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, attractive valuation levels and good cash flow from operations. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Intuitive Surgical ( ISRG) is up $5.09 (1.2%) to $435.23 on average volume. Thus far, 335,215 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 479,300 shares. The stock has ranged in price between $433.00-$447.50 after having opened the day at $444.94 as compared to the previous trading day's close of $430.14.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $16.4 billion and is part of the health care sector. The company has a P/E ratio of 25.7, above the S&P 500 P/E ratio of 17.7. Shares are up 12.0% year-to-date as of the close of trading on Friday. Currently there are 8 analysts who rate Intuitive Surgical a buy, 4 analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and weak operating cash flow. Get the full Intuitive Surgical Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is up $0.63 (0.9%) to $74.25 on light volume. Thus far, 1.3 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.7 million shares. The stock has ranged in price between $73.73-$74.44 after having opened the day at $74.35 as compared to the previous trading day's close of $73.62.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. It offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $59.3 billion and is part of the health care sector. The company has a P/E ratio of 31.9, above the S&P 500 P/E ratio of 17.7. Shares are up 4.8% year-to-date as of the close of trading on Friday. Currently there are 13 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, good cash flow from operations, solid stock price performance, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Futures Fall on Further Trade Rhetoric from China and 4 Other Stories to Watch

Futures Fall on Further Trade Rhetoric from China and 4 Other Stories to Watch

5 Biggest U.S. Tech Stocks Test $4 Trillion Valuation Amid Bullish Nasdaq Run

5 Biggest U.S. Tech Stocks Test $4 Trillion Valuation Amid Bullish Nasdaq Run

Trade War Fear Creeps Back Into Markets on Thursday

Trade War Fear Creeps Back Into Markets on Thursday

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Trade Tussle Sinks Stocks, Oil Slides, Micron, Daimler - 5 Things You Must Know

Daimler Slumps After Profit Warning Cites 'Import Tariffs' in US-China Trade War

Daimler Slumps After Profit Warning Cites 'Import Tariffs' in US-China Trade War